HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans.
about
Randomized, Double-Blind, Crossover Trial of Amitriptyline for Analgesia in Painful HIV-Associated Sensory NeuropathyScreening for HIV-associated peripheral neuropathy in resource-limited settingsSensory, psychological, and metabolic dysfunction in HIV-associated peripheral neuropathy: A cross-sectional deep profiling study.Symptomatology of peripheral neuropathy in an African languageRole of TNF block genetic variants in HIV-associated sensory neuropathy in black Southern Africans.Neurology and the Global HIV Epidemic.Training needs and evaluation of a neuro-HIV training module for non-physician healthcare workers in western KenyaThe relationship between race and HIV-distal sensory polyneuropathy in a large cohort of US women[Neuropathies related to HIV/AIDS: a clinical study in patients infected with HIV a Centre of Excellence HIV/AIDS of the University of Lubumbashi].Development, Validation, and Field-Testing of an Instrument for Clinical Assessment of HIV-Associated Neuropathy and Neuropathic Pain in Resource-Restricted and Large Population Study SettingsEffects of a reduced dose of stavudine on the incidence and severity of peripheral neuropathy in HIV-infected adults in South AfricaIncreased incidence of symptomatic peripheral neuropathy among adults receiving stavudine- versus zidovudine-based antiretroviral regimens in Kenya.HIV-related neuropathy: current perspectives.Pain in people living with HIV/AIDS: a systematic review.Prevalent neuropathy in a cohort of HIV-infected Kenyan sex workers using antiretroviral drugs.HIV-associated sensory neuropathy: risk factors and genetics.Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models.Painful HIV-associated sensory neuropathy.The issues around opioid prescribing in HIV-related pain.Drug-induced peripheral neuropathy.Diagnosing and treating HIV-associated sensory neuropathy: a global perspective.Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial.Genetics of HIV-associated sensory neuropathy and related pain in Africans.Psychological Factors Associated With Painful Versus Non-Painful HIV-Associated Sensory Neuropathy.Polymorphisms in CAMKK2 may predict sensory neuropathy in African HIV patients.High prevalence of distal sensory polyneuropathy in antiretroviral-treated and untreated people with HIV in Tanzania.TNF haplotypes in a Southern African population resemble those seen in Caucasians and Asians.Pain in ambulatory HIV-positive South Africans.Current perspectives on HIV-related pain and its management: insights from sub-Saharan Africa.An innovative approach to reducing pain in patients with peripheral neuropathy related to HIV: A single case study.A prospective study of demographic features and quality of life in HIV-positive women with cervical cancer treated at Tygerberg Hospital.
P2860
Q28547239-78FC291D-BF6C-4E79-B3BD-C6C00E73F126Q33603950-A1D94697-F34E-47F5-BE08-B4676D26B48EQ34194723-56B29AD0-669B-4712-89C4-B9F437D9F04FQ34731211-F171E041-1853-4223-BF59-C6CA39F4F174Q35079928-D363DC2C-9C11-4DC2-9473-2603AD6F0B3EQ35149362-7758DF86-CC12-42D7-AAED-8756BA9D2973Q35195299-55910727-B8E5-4086-8D93-AFADFBEF1294Q35823133-938B659E-A0D9-481B-B1C2-A4C5AC5555CFQ35842968-8E96AFC3-DDE8-4039-9745-78F25CAB677CQ36169291-8C479E12-DF22-4DF7-9E3F-827B132E3CC1Q36870758-288F8189-76B5-4FE3-BFAF-B34BACD01C11Q37053758-084955CE-96C5-43A9-9A82-EC44DBE0A631Q37178574-7E4C3C87-1018-4EA9-9B0C-3AD04BE86FC4Q37594591-23C2F26C-30E7-4A1B-B3B9-6E454B227FB7Q37608857-29670CF0-9BAD-4295-8B47-2DF2D2E79EC6Q37988382-4D1BD909-01EE-4A4D-A1C4-B4F7D5F8F4E1Q37998517-87EAC35C-EFE3-4DFA-A1C0-B1FCC8B2AAACQ38197249-76BD7046-BB9B-4AE5-896B-A01F8963DC20Q38198106-8326092E-E15F-4125-A385-466CFC2D872EQ38208565-4FFE5D20-AA5B-40E6-A7E0-2B94BA565509Q38778861-5C117B45-571D-4A48-80D0-5436176C4E60Q38857895-F2908DF1-E576-42E8-9398-E3AE07550AE7Q39339843-1A21210E-15FF-4CE2-A32C-88E8C5DA8B3EQ40133910-0B1C86DA-C771-4E60-AF48-6CCC5A2065C9Q40826704-5AAE0609-926C-4D56-BD9F-017213876A7FQ43940258-D131216D-2A16-49BA-8B88-8C004C63152CQ46092358-A3441752-96A5-4049-980D-8627162EE4D2Q48659032-503916E1-F2D2-4E9E-99A8-837E860C710DQ48810942-FB362E11-3940-4B7F-92FC-47DDE26827E4Q51829019-25C6D566-4AB1-45BD-BF71-DB597B752BE1Q55155663-6ED12D28-9B70-4EE9-9A51-C8FD10ABED4E
P2860
HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
HIV neuropathy risk factors an ...... vudine-exposed South Africans.
@en
HIV neuropathy risk factors an ...... vudine-exposed South Africans.
@nl
type
label
HIV neuropathy risk factors an ...... vudine-exposed South Africans.
@en
HIV neuropathy risk factors an ...... vudine-exposed South Africans.
@nl
prefLabel
HIV neuropathy risk factors an ...... vudine-exposed South Africans.
@en
HIV neuropathy risk factors an ...... vudine-exposed South Africans.
@nl
P50
P1476
HIV neuropathy risk factors an ...... vudine-exposed South Africans.
@en
P2093
Patricia Price
P304
P356
10.1016/J.JPAINSYMMAN.2010.07.006
P577
2010-12-08T00:00:00Z